Related Experiment Videos
[Carcinosarcoma of the esophagus]
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|May 1, 1993
Summary
Carcinosarcoma of the esophagus is a rare dual-element neoplasm. Radical esophagectomy with lymph node dissection is the standard treatment for this esophageal cancer.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Esophageal carcinosarcoma is a rare malignant neoplasm characterized by both carcinomatous and sarcomatous components.
- This study reports on two cases of esophageal carcinosarcoma treated at a single institution between 1982 and 1991.
Observation:
- Two cases of esophageal carcinosarcoma were identified among 516 esophageal neoplasms (0.39%).
- Both patients were male, aged 62 and 68, with tumors located in the middle esophagus. Pathological stages were III (T3N2M0) and I (T1N0M0).
- Surgical management involved subtotal esophagectomy, mediastinal lymph node dissection, and retrosternal esophagogastrostomy.
Findings:
- The patient with stage III disease achieved a 7-year disease-free survival post-surgery.
- The patient with stage I disease died within one year due to intra-abdominal lymphadenopathy, liver metastasis, and ascites.
Implications:
- Radical esophagectomy with lymph node dissection, similar to the approach for squamous cell carcinoma, is recommended for esophageal carcinosarcoma.
- Further research is needed to understand the prognostic factors and optimize treatment strategies for this rare esophageal cancer.